These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 33622900

  • 1. Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy.
    Hasegawa Y, Matsubara N, Kogawa T, Naito Y, Harano K, Hosono A, Onishi T, Hojo T, Shimokawa M, Mukohara T.
    In Vivo; 2021; 35(2):1041-1049. PubMed ID: 33622900
    [Abstract] [Full Text] [Related]

  • 2. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
    Resende U, Cabello C, Ramalho SOB, Zeferino LC.
    BMC Cancer; 2019 Jun 17; 19(1):601. PubMed ID: 31208353
    [Abstract] [Full Text] [Related]

  • 3. Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore.
    Steenbruggen TG, van Seijen M, Janssen LM, van Ramshorst MS, van Werkhoven E, Vrancken Peeters MTDF, Wesseling J, Lips EH, Sonke GS.
    Clin Cancer Res; 2019 Aug 15; 25(16):4985-4992. PubMed ID: 31076546
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Bergquist JR, Murphy BL, Storlie CB, Habermann EB, Boughey JC.
    Ann Surg Oncol; 2017 Nov 15; 24(12):3510-3517. PubMed ID: 28828583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A study on the correlation between Neo-Bioscoresystem and disease-free survival of breast cancer patients with neoadjuvant chemotherapy].
    Wang GC, Xu FR, Li JB, Liu W, Bian L, Zhang SH, Wang T, Song ST, Jiang ZF.
    Zhonghua Yi Xue Za Zhi; 2017 Aug 08; 97(30):2349-2352. PubMed ID: 28822452
    [Abstract] [Full Text] [Related]

  • 12. External verification and improvement of the Neo-Bioscore staging system in a Chinese cohort.
    Geng R, Min N, Zheng Y, Hong C, Wu R, Wu H, Wei Y, Zhang Y, Li X.
    Ann Transl Med; 2022 Jun 08; 10(11):626. PubMed ID: 35813331
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.
    Hamy AS, Lam GT, Laas E, Darrigues L, Balezeau T, Guerin J, Livartowski A, Sadacca B, Pierga JY, Vincent-Salomon A, Coussy F, Becette V, Bonsang-Kitzis H, Rouzier R, Feron JG, Benchimol G, Laé M, Reyal F.
    Breast Cancer Res Treat; 2018 Jun 08; 169(2):295-304. PubMed ID: 29374852
    [Abstract] [Full Text] [Related]

  • 20. Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response.
    Elnemr GM, El-Rashidy AH, Osman AH, Issa LF, Abbas OA, Al-Zahrani AS, El-Seman SM, Mohammed AA, Hassan AA.
    Asian Pac J Cancer Prev; 2016 Jun 08; 17(2):807-13. PubMed ID: 26925684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.